title: Reply: To PMID 25443902.
authors.affiliation: Division of Geriatrics, San Francisco VA Medical Center and University of California, San Francisco, CA.
authors.forename: Ying
authors.initials: Y
authors.lastname: Shi
authors.affiliation: Division of Geriatrics, San Francisco VA Medical Center and University of California, San Francisco, CA.
authors.forename: W John
authors.initials: WJ
authors.lastname: Boscardin
authors.affiliation: Division of Geriatrics, San Francisco VA Medical Center and University of California, San Francisco, CA.
authors.forename: Louise C
authors.initials: LC
authors.lastname: Walter
mesh_terms: D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood*
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D017430:Prostate-Specific Antigen